Energy expenditure, urea kinetics, and body weight gain within a segregating resource family population

Common and diet-specific metabolic pathways underlying residual feed intake in fattening Charolais yearling bulls

Residual feed intake (RFI) is one of the preferred traits for feed efficiency animal breeding. However, RFI measurement is expensive and time-consuming and animal ranking may depend on the nature of the diets. We aimed to explore RFI plasma biomarkers and to unravel the underlying metabolic pathways in yearling bulls fed either a corn-silage diet rich in starch (corn diet) or a grass-silage diet rich in fiber (grass diet). Forty-eight extreme RFI animals (Low-RFI, n = 24, versus High-RFI, n = 24, balanced per diet) were selected from a population of 364 Charolais bulls and their plasma was subjected to a targeted LC-MS metabolomic approach together with classical metabolite and hormonal plasma analyses. Greater lean body mass and nitrogen use efficiency, and lower protein turnover were identified as common mechanisms underlying RFI irrespective of the diet. On the other hand, greater adiposity and plasma concentrations of branched-chain amino acids (BCAA) together with lower insulin sensitivity in High-RFI animals were only observed with corn diet. Conversely, greater plasma concentrations of BCAA and total triglycerides, but similar insulin concentrations were noted in efficient RFI cattle with grass diet. Our data suggest that there are diet-specific mechanisms explaining RFI differences in fattening Charolais yearling bulls.

A novel doubly labelled 13C, 15N amino acid method for measuring energy and protein metabolism in man

A novel doubly [1-¹³C, α-¹⁵NH₂]-labelled amino acid method (DLAAM) is presented for the determination of the CO₂ production (RCO₂) and energy expenditure in humans. This method is based on the simultaneous administration of [1-¹³C]glycine and [¹⁵N]glycine followed by the measurement of excretion kinetics of breath ¹³CO₂ and urinary ¹⁵N. The basic idea of the DLAAM is that the unknown ¹³C recovery RF(¹³C) of the 1-¹³C amino acid, essential for the calculation of the net CO₂ production, can be approximated by the easily measureable ¹⁵N recovery RF(¹⁵N) of the α-¹⁵NH₂ labelled amino acid. In four healthy adult men (76-97 kg) the DLAAM was tested parallel to the IC and in one man (74 kg) parallel to the DLWM. Using the approximation RF(¹³C) ≈ RF(¹⁵N) the RCO₂ (in l CO₂ d^-1) was calculated to 387.0 ± 30.3 (DLAAM) vs. 382.8 ± 22.6. (IC). The Bland-Altman plot shows that the difference between the DLAAM and IC of individual RCO₂ is within the 95 % confidence interval (mean ± 2 SD): +4.3 ± 37.5 l CO₂ d^-1. We conclude that the DLAAM and IC may be used interchangeably. The physical activity level (PAL) was calculated based on the DLAAM vs. DLWM to about 1.5.

Retinol binding protein 4 abundance in plasma and tissues is related to body fat deposition in cattle

Retinol binding protein 4 (RBP4) facilitates the transport of retinol in the body but is also an adipokine and fatty acid transporter. Our study was aimed at investigating the associations between RBP4 abundance and fat deposition in cattle. Blood samples of 246 crossbred bulls were taken at 8 months of age and at slaughter at 18 months of age for the determination of RBP4, hormone levels, and fatty acid composition. Significant correlations between plasma RBP4 abundance at 8 months of age and carcass traits at 18 months of age were detected (e.g., r = 0.3; P < 0.001 to carcass fat). Furthermore, RBP4 abundances in the plasma and subcutaneous fat were higher (P < 0.05) in bulls with increased fat deposition, whereas the liver RBP4 expression was not (P > 0.05). Retinol binding protein 4 was immunohistochemically localized in or close to adipocytes within muscle and adipose tissue and in liver stellate cells but not in hepatocytes. Overall, our results indicate that increased RBP4 levels were associated with increased fat deposition and altered fatty acid composition, but not with altered glucose tolerance, in crossbred bulls. Moreover, our results suggest that adipose-tissue-derived RBP4 may contribute to the circulating RBP4 level.